Pfizer Inc (PFE)
25.26
-1.01
(-3.84%)
USD |
NYSE |
Apr 25, 16:00
25.50
+0.24
(+0.95%)
Pre-Market: 07:29
Pfizer Cash from Investing (TTM): -32.28B for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -32.28B |
September 30, 2023 | -25.69B |
June 30, 2023 | -27.21B |
March 31, 2023 | -13.04B |
December 31, 2022 | -15.78B |
September 30, 2022 | -13.96B |
June 30, 2022 | -23.41B |
March 31, 2022 | -20.23B |
December 31, 2021 | -22.55B |
September 30, 2021 | -11.63B |
June 30, 2021 | -1.073B |
March 31, 2021 | -5.947B |
December 31, 2020 | -4.271B |
September 30, 2020 | -15.43B |
June 30, 2020 | -22.68B |
March 31, 2020 | -11.57B |
December 31, 2019 | -3.945B |
September 30, 2019 | -1.876B |
June 30, 2019 | 1.98B |
March 31, 2019 | 2.408B |
December 31, 2018 | 4.525B |
September 30, 2018 | 530.00M |
June 30, 2018 | 423.00M |
March 31, 2018 | 159.00M |
December 31, 2017 | -4.74B |
Date | Value |
---|---|
September 30, 2017 | -3.068B |
June 30, 2017 | -4.438B |
March 31, 2017 | -7.378B |
December 31, 2016 | -7.791B |
September 30, 2016 | -6.928B |
June 30, 2016 | -7.79B |
March 31, 2016 | -5.217B |
December 31, 2015 | -2.98B |
September 30, 2015 | -2.27B |
June 30, 2015 | 438.00M |
March 31, 2015 | 1.036B |
December 31, 2014 | -5.654B |
September 30, 2014 | -3.998B |
June 30, 2014 | -2.066B |
March 31, 2014 | 284.00M |
December 31, 2013 | -10.54B |
September 30, 2013 | -3.849B |
June 30, 2013 | -3.493B |
March 31, 2013 | -5.223B |
December 31, 2012 | 6.154B |
September 30, 2012 | -141.00M |
June 30, 2012 | 321.00M |
March 31, 2012 | 1.569B |
December 31, 2011 | 1.843B |
September 30, 2011 | -4.344B |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-32.28B
Minimum
Dec 2023
1.98B
Maximum
Jun 2019
-14.24B
Average
-13.96B
Median
Sep 2022
Cash from Investing (TTM) Benchmarks
Amgen Inc | -26.20B |
Gilead Sciences Inc | -2.265B |
Johnson & Johnson | 878.00M |
Viking Therapeutics Inc | -641.08M |
Moderna Inc | 4.206B |